Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmathen Global BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10794
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain killers, besides topical antifungals, corticosteroids, and vitamins and minerals. Pharmathen provides comprehensive backward integrated services to customers, which include API systhesis to formulation, and production and supply of finished products. It also offers services which include drug safety and pharmacovigilance, third party auditing, regulatory affairs, quality management, medical writing and consulting services, intellectual property, and scientific operations. The company markets its products in Europe, North America, South Africa, Latin America, Middle East and North Africa, Asia and Australia. Pharmathen is headquartered in Amstelveen, Netherlands.

Pharmathen Global BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
BC Partners to Acquire Majority Stake in Pharmathen 10
Partnerships 11
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Asset Transactions 17
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV – Key Competitors 18
Pharmathen Global BV – Key Employees 19
Pharmathen Global BV – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Pharmathen Global BV, Pharmaceuticals & Healthcare, Key Facts 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BC Partners to Acquire Majority Stake in Pharmathen 10
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV, Key Competitors 18
Pharmathen Global BV, Key Employees 19
Pharmathen Global BV, Other Locations 20
Pharmathen Global BV, Subsidiaries 20

List of Figures
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bonduelle Sca
    Bonduelle Sca - Strategy, SWOT and Corporate Finance Report Summary Bonduelle Sca - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務分析
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Orkuveita Reykjavikur:企業の戦略的SWOT分析
    Orkuveita Reykjavikur - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sandoz Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sandoz Inc (Sandoz), a division of Novartis AG (Novartis), is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars. The company also provides intermediary products including active pharmaceutical …
  • Carrefour SA:企業のM&A・事業提携・投資動向
    Carrefour SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carrefour SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Unitil Corp (UTL):企業の財務・戦略的SWOT分析
    Summary Unitil Corp (Unitil) is an interstate electricity and natural gas utility company. The company offers construction, operation and maintenance of gas and electric distribution systems. Unitil offers business operations such as electricity distribution, gas distribution utility operations and …
  • Nippon Shikizai Inc.:企業の戦略・SWOT・財務分析
    Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report Summary Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • InnoMedica Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • IBC Solar AG:電力:M&Aディール及び事業提携情報
    Summary IBC Solar AG (IBC Solar), formerly IBC Solartechnik, is a solar energy company that provides photovoltaic and energy storage solutions and services. The company’s product range includes solar parks, self-consumption systems for commercial enterprises and private households, diesel hybrid sol …
  • AirStrip Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform, accelerator services and wireless maternal-fetal monitoring solutions. It caters its products to healthcare provide …
  • A.G.Barr p.l.c.:企業の戦略・SWOT・財務情報
    A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report Summary A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • 10X Genomics, Inc.:製薬・医療:M&Aディール及び事業提携情報
    Summary 10X Genomics, Inc. (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single cell ATAC sequencer and single cell with barcode technology. It offers single cell gene expression, single cell immune profiling …
  • Odebrecht SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Odebrecht S.A. (Odebrecht) is a diversified company. It carries out engineering and infrastructure construction services, development and operation of energy and infrastructure projects and real estate development services. The company executed various engineering and construction projects s …
  • Biotest Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest Pharmaceuticals Corp (Biotest Pharmaceuticals), a subsidiary of Biotest AG, is a manufacturer and distributor of of pharmaceutical and biotherapeutic products. The company offers products such as bivigam, nabi hb, hepatitis c immune globulin and plasma for further manufacturing. It o …
  • CA Technologies, Inc.:企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Quest Diagnostics Inc (DGX):企業の財務・戦略的SWOT分析
    Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆